| Anaemia | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0004 events4 affected43 at risk
- EG00122 events20 affected84 at risk
- EG00221 events18 affected84 at risk
|
| Eosinophilia | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Febrile neutropenia | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0024 events3 affected84 at risk
|
| Leukocytosis | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Leukopenia | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0003 events2 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Lymphadenopathy | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Neutropenia | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG00012 events10 affected43 at risk
- EG00126 events9 affected84 at risk
- EG00219 events17 affected84 at risk
|
| Neutrophilia | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Thrombocytopenia | Blood and lymphatic system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0023 events2 affected84 at risk
|
| Arrhythmia | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Atrial fibrillation | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0024 events3 affected84 at risk
|
| Atrial flutter | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Atrial tachycardia | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Bundle branch block left | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Cardiac failure | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Cardiac failure congestive | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Mitral valve incompetence | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nodal rhythm | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Palpitations | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pericarditis | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Right ventricular failure | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Sinus tachycardia | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Supraventricular tachycardia | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Tachycardia | Cardiac disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Deafness | Ear and labyrinth disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hearing impaired | Ear and labyrinth disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Middle ear inflammation | Ear and labyrinth disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Otorrhoea | Ear and labyrinth disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Tinnitus | Ear and labyrinth disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Vertigo | Ear and labyrinth disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Hyperthyroidism | Endocrine disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Blepharitis | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Chorioretinal disorder | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Conjunctival haemorrhage | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Dry eye | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Eye discharge | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Eye disorder | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Eye irritation | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Eye oedema | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Eye pain | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Eye swelling | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Eyelid oedema | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0025 events2 affected84 at risk
|
| Eyelid pain | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Lacrimation increased | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0027 events7 affected84 at risk
|
| Noninfective conjunctivitis | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Periorbital oedema | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0024 events3 affected84 at risk
|
| Vision blurred | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Visual acuity reduced | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Visual impairment | Eye disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Abdominal discomfort | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Abdominal distension | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0013 events2 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Abdominal pain | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0004 events3 affected43 at risk
- EG00112 events9 affected84 at risk
- EG0026 events6 affected84 at risk
|
| Abdominal pain lower | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Abdominal pain upper | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0005 events4 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0029 events8 affected84 at risk
|
| Abdominal rigidity | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Anal haemorrhage | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Aphthous ulcer | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Breath odour | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Buccal mucosal roughening | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Chapped lips | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Cheilitis | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0005 events5 affected43 at risk
- EG00118 events16 affected84 at risk
- EG00213 events11 affected84 at risk
|
| Dental cyst | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Diarrhoea | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG00021 events12 affected43 at risk
- EG00178 events41 affected84 at risk
- EG00265 events37 affected84 at risk
|
| Diarrhoea haemorrhagic | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Diverticulum | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Dry mouth | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Dyspepsia | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG00010 events4 affected43 at risk
- EG0016 events6 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Dysphagia | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Eructation | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Flatulence | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Gastric ulcer | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Gastritis | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Gastrointestinal haemorrhage | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Gastrooesophageal reflux disease | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0026 events6 affected84 at risk
|
| Glossitis | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Glossodynia | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Haematochezia | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Haemorrhoidal haemorrhage | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Haemorrhoids | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hiatus hernia | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hyperchlorhydria | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Hypoaesthesia oral | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Intra-abdominal haematoma | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Lip erosion | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Mouth haemorrhage | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Mouth ulceration | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Nausea | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG00022 events10 affected43 at risk
- EG00133 events25 affected84 at risk
- EG00236 events23 affected84 at risk
|
| Odynophagia | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Oesophagitis | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Oral mucosal eruption | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Oral pain | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Paraesthesia oral | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Rectal haemorrhage | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Retroperitoneal haematoma | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Steatorrhoea | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Stomatitis | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0007 events5 affected43 at risk
- EG00111 events11 affected84 at risk
- EG00233 events23 affected84 at risk
|
| Tooth loss | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Toothache | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Vomiting | Gastrointestinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG00013 events8 affected43 at risk
- EG00128 events20 affected84 at risk
- EG00227 events22 affected84 at risk
|
| Asthenia | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG00112 events12 affected84 at risk
- EG00214 events13 affected84 at risk
|
| Catheter site related reaction | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Chest discomfort | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Chest pain | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Chills | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Extravasation | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Face oedema | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Fatigue | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG00017 events13 affected43 at risk
- EG00121 events17 affected84 at risk
- EG00232 events26 affected84 at risk
|
| General physical health deterioration | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Generalised oedema | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Hyperthermia | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Influenza like illness | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Malaise | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Mucosal inflammation | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0028 events7 affected84 at risk
|
| Non-cardiac chest pain | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Oedema | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Oedema peripheral | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG00010 events8 affected43 at risk
- EG00122 events16 affected84 at risk
- EG00238 events28 affected84 at risk
|
| Pain | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Performance status decreased | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Pyrexia | General disorders | MedDRA 18.1 | Systematic Assessment | | - EG0005 events3 affected43 at risk
- EG00115 events11 affected84 at risk
- EG00220 events11 affected84 at risk
|
| Hepatic steatosis | Hepatobiliary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Liver disorder | Hepatobiliary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Drug hypersensitivity | Immune system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Angular cheilitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Bronchitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0026 events6 affected84 at risk
|
| Candida infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Cellulitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Clostridium colitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Conjunctivitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0025 events5 affected84 at risk
|
| Diverticulitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Ear infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Erysipelas | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Folliculitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Fungal skin infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Gastroenteritis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Gastrointestinal infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Gingivitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Laryngitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Lung infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Mastitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nasopharyngitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0003 events3 affected43 at risk
- EG0015 events4 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nosocomial infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Ophthalmic herpes zoster | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Oral candidiasis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0004 events3 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Oral fungal infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0015 events4 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Oral infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Paronychia | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0029 events7 affected84 at risk
|
| Peritonitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pharyngitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pneumonia | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Rash pustular | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0027 events5 affected84 at risk
|
| Respiratory tract infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Respiratory tract infection bacterial | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Rhinitis | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Septic shock | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Skin infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Staphylococcal infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Upper respiratory tract infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Urinary tract infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0017 events5 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Viral upper respiratory tract infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Vulvovaginal mycotic infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Wound infection | Infections and infestations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Animal bite | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Bone contusion | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Contusion | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0024 events3 affected84 at risk
|
| Fall | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Head injury | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Laceration | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Lumbar vertebral fracture | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Overdose | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Rib fracture | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Seroma | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Skin abrasion | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Spinal compression fracture | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Sunburn | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Tendon rupture | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Wound | Injury, poisoning and procedural complications | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Alanine aminotransferase increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Aspartate aminotransferase increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Blood calcium decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Blood creatine phosphokinase MB increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Blood creatine phosphokinase increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG00111 events3 affected84 at risk
- EG00211 events5 affected84 at risk
|
| Blood creatinine increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Blood lactate dehydrogenase increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Blood magnesium decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Blood pressure systolic increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Blood sodium decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Blood triglycerides increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Breath sounds abnormal | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| C-reactive protein increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Ejection fraction decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Haemoglobin decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hepatic enzyme abnormal | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Hepatic enzyme increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| International normalised ratio increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Intraocular pressure increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Platelet count decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Prothrombin time prolonged | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Weight decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0004 events4 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0026 events6 affected84 at risk
|
| Weight increased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| White blood cell count decreased | Investigations | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Abnormal loss of weight | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Central obesity | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Decreased appetite | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG00010 events10 affected43 at risk
- EG00121 events21 affected84 at risk
- EG00220 events18 affected84 at risk
|
| Dehydration | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Diabetes mellitus | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Fluid overload | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Hyperkalaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0023 events2 affected84 at risk
|
| Hyperphosphataemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Hypoalbuminaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0003 events2 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0023 events2 affected84 at risk
|
| Hypocalcaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hypoglycaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Hypokalaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0015 events5 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0003 events3 affected43 at risk
- EG0014 events3 affected84 at risk
- EG0023 events2 affected84 at risk
|
| Hyponatraemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Hypophagia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hypoproteinaemia | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Vitamin K deficiency | Metabolism and nutrition disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Arthralgia | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0017 events6 affected84 at risk
- EG0025 events4 affected84 at risk
|
| Back pain | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0004 events4 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0027 events7 affected84 at risk
|
| Bone pain | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Joint swelling | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Limb discomfort | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Muscle spasms | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Muscular weakness | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0017 events4 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Musculoskeletal chest pain | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0004 events4 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Musculoskeletal discomfort | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Musculoskeletal pain | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Myalgia | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0005 events5 affected43 at risk
- EG0016 events6 affected84 at risk
- EG00210 events9 affected84 at risk
|
| Myopathy | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Neck pain | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Osteitis | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pain in extremity | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0007 events6 affected43 at risk
- EG0015 events4 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Spinal pain | Musculoskeletal and connective tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Oncologic complication | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Tumour pain | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Ageusia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Amnesia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Ataxia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Depressed level of consciousness | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Dizziness | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0007 events7 affected43 at risk
- EG0015 events5 affected84 at risk
- EG0025 events5 affected84 at risk
|
| Dizziness postural | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Dysaesthesia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Dysarthria | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Dysgeusia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0003 events3 affected43 at risk
- EG0016 events6 affected84 at risk
- EG0028 events8 affected84 at risk
|
| Head discomfort | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Headache | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0005 events5 affected43 at risk
- EG0016 events6 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Hemiparesis | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Hepatic encephalopathy | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hypoaesthesia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hypokinesia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hypotonia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Lethargy | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Memory impairment | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Neuropathy peripheral | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0014 events3 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Peripheral motor neuropathy | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Peripheral sensory neuropathy | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Polyneuropathy | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0014 events4 affected84 at risk
- EG0024 events3 affected84 at risk
|
| Somnolence | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Syncope | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Tremor | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Vocal cord paralysis | Nervous system disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Anxiety | Psychiatric disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Delirium | Psychiatric disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Depression | Psychiatric disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Disorientation | Psychiatric disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Insomnia | Psychiatric disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0015 events4 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Sleep disorder | Psychiatric disorders | MedDRA 18.1 | Systematic Assessment | | - EG0003 events2 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Acute kidney injury | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Bladder pain | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Costovertebral angle tenderness | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Dysuria | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0026 events5 affected84 at risk
|
| Oliguria | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Pollakiuria | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Proteinuria | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Renal cyst | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Renal failure | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Renal impairment | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Renal infarct | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Renal vein thrombosis | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Balanoposthitis | Reproductive system and breast disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Pelvic pain | Reproductive system and breast disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Vulvovaginal pruritus | Reproductive system and breast disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Atelectasis | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Bronchospasm | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Chronic obstructive pulmonary disease | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Cough | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0008 events8 affected43 at risk
- EG0017 events7 affected84 at risk
- EG00210 events10 affected84 at risk
|
| Dysphonia | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0004 events4 affected43 at risk
- EG00112 events12 affected84 at risk
- EG00215 events14 affected84 at risk
|
| Dyspnoea exertional | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Emphysema | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Epistaxis | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0003 events2 affected43 at risk
- EG0016 events6 affected84 at risk
- EG0029 events8 affected84 at risk
|
| Haemoptysis | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0028 events7 affected84 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Lung disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Lung infiltration | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nasal discomfort | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nasal dryness | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nasal inflammation | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nasal polyps | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Oropharyngeal pain | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0025 events5 affected84 at risk
|
| Pharyngeal inflammation | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Pleuritic pain | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Pneumonitis | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Productive cough | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pulmonary haemorrhage | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pulmonary hypertension | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Pulmonary oedema | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Rales | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Rhinitis allergic | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Rhinorrhoea | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Sinus disorder | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Sputum discoloured | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Wheezing | Respiratory, thoracic and mediastinal disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Acne | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Alopecia | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0008 events8 affected43 at risk
- EG00111 events11 affected84 at risk
- EG00216 events15 affected84 at risk
|
| Dermatitis | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Dermatitis acneiform | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG00118 events9 affected84 at risk
- EG0029 events7 affected84 at risk
|
| Dermatitis exfoliative | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Dry skin | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG00110 events9 affected84 at risk
- EG00216 events16 affected84 at risk
|
| Eczema | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Erythema | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0015 events4 affected84 at risk
- EG0026 events5 affected84 at risk
|
| Erythema multiforme | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hyperhidrosis | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Ingrowing nail | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Intertrigo | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Madarosis | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nail discolouration | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Nail disorder | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0013 events3 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nail growth abnormal | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Nail ridging | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Night sweats | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Onychalgia | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events1 affected84 at risk
|
| Onychoclasis | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Onycholysis | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Onychomadesis | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Palmar-plantar erythrodysaesthesia syndrome | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0001 events1 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Petechiae | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Photosensitivity reaction | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0023 events2 affected84 at risk
|
| Pruritus | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0015 events4 affected84 at risk
- EG0024 events4 affected84 at risk
|
| Rash | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG00010 events9 affected43 at risk
- EG00126 events23 affected84 at risk
- EG00244 events29 affected84 at risk
|
| Rash erythematous | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Rash generalised | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Rash macular | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0013 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Rash maculo-papular | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0023 events3 affected84 at risk
|
| Rash papular | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Rash pruritic | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Rosacea | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Skin exfoliation | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Skin fissures | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events2 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Skin hyperpigmentation | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Skin ulcer | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Swelling face | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Urticaria | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0012 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Xeroderma | Skin and subcutaneous tissue disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Circulatory collapse | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Embolism | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Flushing | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0003 events3 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hot flush | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Hypertension | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0004 events3 affected43 at risk
- EG0012 events2 affected84 at risk
- EG00211 events10 affected84 at risk
|
| Hypotension | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Lymphoedema | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0022 events2 affected84 at risk
|
| Orthostatic hypotension | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0010 events0 affected84 at risk
- EG0021 events1 affected84 at risk
|
| Peripheral coldness | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Phlebitis | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0002 events2 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Superior vena cava syndrome | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0020 events0 affected84 at risk
|
| Thrombophlebitis | Vascular disorders | MedDRA 18.1 | Systematic Assessment | | - EG0000 events0 affected43 at risk
- EG0011 events1 affected84 at risk
- EG0021 events1 affected84 at risk
|